His primary scientific interests are in Cornea, Lymphangiogenesis, Ophthalmology, Pathology and Surgery. His Cornea research includes elements of Angiogenesis, Corneal neovascularization and Neovascularization. His work deals with themes such as Inflammation, Lymphatic system, Immunology, Vascular endothelial growth factor A and Cell biology, which intersect with Lymphangiogenesis.
Claus Cursiefen interconnects Receptor, CD31, Endothelium and Lymph in the investigation of issues within Lymphatic system. His Biopsy study in the realm of Pathology interacts with subjects such as Basal cell carcinoma. In his research, Corneal allograft rejection, Allograft rejection, Atopic dermatitis, Endothelial corneal allograft rejection and Immune reaction is intimately related to Incidence, which falls under the overarching field of Surgery.
Claus Cursiefen mainly focuses on Ophthalmology, Cornea, Pathology, Lymphangiogenesis and Surgery. In his work, Bevacizumab is strongly intertwined with Corneal neovascularization, which is a subfield of Ophthalmology. His work carried out in the field of Cornea brings together such families of science as Neovascularization and Transplantation.
His Pathology study frequently draws connections to other fields, such as Melanoma. His Lymphangiogenesis research is multidisciplinary, incorporating perspectives in Inflammation, Immunology and Cancer research, Angiogenesis. His Lymphatic system research is multidisciplinary, incorporating elements of CD31 and Lymphatic vessel.
His primary areas of study are Ophthalmology, Descemet membrane, Cornea, Gynecology and Visual acuity. While the research belongs to areas of Ophthalmology, Claus Cursiefen spends his time largely on the problem of Corneal neovascularization, intersecting his research to questions surrounding Clinical trial. His work on Fuchs Endothelial Dystrophy as part of general Descemet membrane study is frequently connected to Outcome measures, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His Cornea research includes themes of Lymphatic system, Transplantation and Lymphangiogenesis. His research in Lymphangiogenesis focuses on subjects like Angiogenesis, which are connected to Pathology. His studies deal with areas such as Significant difference, Retrospective cohort study and Cataract surgery as well as Visual acuity.
Claus Cursiefen spends much of his time researching Ophthalmology, Cornea, Descemet membrane, Lymphatic system and Lymphangiogenesis. Claus Cursiefen has researched Cornea in several fields, including Immune privilege and Surgery, Transplantation. His Descemet membrane research focuses on subjects like Lamellar keratoplasty, which are linked to Significant difference, Endothelial cell count, Donor tissue, Retrospective review and Endothelial cell density.
His Lymphatic system study introduces a deeper knowledge of Pathology. His Pathology research incorporates elements of Corneal Injury and Corneal wound. His Lymphangiogenesis study combines topics from a wide range of disciplines, such as Angiogenesis and Lymphatic vessel.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment
Claus Cursiefen;Lu Chen;Leonardo P. Borges;David Jackson.
Journal of Clinical Investigation (2004)
Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages
Kazuichi Maruyama;Masaaki Ii;Claus Cursiefen;Claus Cursiefen;David G. Jackson.
Journal of Clinical Investigation (2005)
Descemet Membrane Endothelial Keratoplasty Versus Descemet Stripping Automated Endothelial Keratoplasty
Theofilos Tourtas;Kathrin Laaser;Bjoern O. Bachmann;Claus Cursiefen.
American Journal of Ophthalmology (2012)
Influence of Photodynamic Therapy on Expression of Vascular Endothelial Growth Factor (VEGF), VEGF Receptor 3, and Pigment Epithelium–Derived Factor
Ursula Schmidt-Erfurth;Ursula Schlötzer-Schrehard;Claus Cursiefen;Stephan Michels.
Investigative Ophthalmology & Visual Science (2003)
Inhibition of Hemangiogenesis and Lymphangiogenesis after Normal–Risk Corneal Transplantation by Neutralizing VEGF Promotes Graft Survival
Claus Cursiefen;Jingtai Cao;Lu Chen;Ying Liu.
Investigative Ophthalmology & Visual Science (2004)
Bevacizumab as a Potent Inhibitor of Inflammatory Corneal Angiogenesis and Lymphangiogenesis
Felix Bock;Jasmine Onderka;Tina Dietrich;Bjo¨rn Bachmann.
Investigative Ophthalmology & Visual Science (2007)
Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.
Claus Cursiefen;Ursula Schlötzer-Schrehardt;Michael Küchle;Lydia Sorokin.
Investigative Ophthalmology & Visual Science (2002)
Cutting Edge: Lymphatic Vessels, Not Blood Vessels, Primarily Mediate Immune Rejections After Transplantation
Tina Dietrich;Felix Bock;Felix Bock;Don Yuen;Deniz Hos.
Journal of Immunology (2010)
A stepwise approach to donor preparation and insertion increases safety and outcome of Descemet membrane endothelial keratoplasty.
Friedrich E Kruse;Kathrin Laaser;Claus Cursiefen;Ludwig M Heindl.
Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision.
Claus Cursiefen;Lu Chen;Magali Saint-Geniez;Pedram Hamrah.
Proceedings of the National Academy of Sciences of the United States of America (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: